Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OmegaD Softgels for Dry Eye Disease
NCT04181593Phase 3Completed
- Sponsor
- OmegaD
- Start
- Nov 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of OmegaD in dry eye disease (DED), sponsored by OmegaD. Started Nov 2019; status: completed.
02
Drugs
OmegaD
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04181593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04181593.